Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shijiazhuang Exploration Pharmaceutical Technology, also known as Tanlu Pharmaceutical, is a specialized contract research organization (CRO) and chemical manufacturer based in Shijiazhuang, China. The company focuses on the custom synthesis and process development of high-end pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and fine chemicals. Its service portfolio includes impurity identification, process optimization, and scale-up production to support global pharmaceutical and biotech firms in their drug discovery efforts. By leveraging its expertise in complex organic synthesis, the firm provides critical chemical building blocks and reference standards for various therapeutic research areas. The company is strategically located in the Shijiazhuang High-tech Industrial Development Zone, a major hub for the Chinese pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shijiazhuang Exploration Pharmaceutical Technology.